Charles Lucas
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmacology top 0.5%
- Pharmacology and Obesity Treatment
Papers in
-
- Hormonal Regulation and Hypertension 9
- Diabetes Management and Research 6
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
-
- Blood Pressure and Hypertension Studies 9
- Renin-Angiotensin System Studies 4
- Cardiovascular Function and Risk Factors 4
- Co-authors
- Jonathan HauptmanSteven B. HeymsfieldJain ChungLinda L. DargaDouglas C. HeimburgerMario DiGirolamoMichael DavidsonJohn P. Foreyt
- Journals
- The American Journal of Cardiology (9 papers)Metabolism (5 papers)The Journal of Clinical Endocrinology & Metabolism (4 papers)The American Journal of Medicine (3 papers)Diabetes (2 papers)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Charles Lucas
54 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Endocrinology, Diabetes and Metabolism 1.4k
- Pharmacology 1.3k
- Physiology 890
- Pharmacy 160
- Endocrine and Autonomic Systems 154
Countries citing papers authored by Charles Lucas
This map shows the geographic impact of Charles Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Lucas more than expected).
Fields of papers citing papers by Charles Lucas
This network shows the impact of papers produced by Charles Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Lucas. The network helps show where Charles Lucas may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Lucas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The old empire and the new | 2010 | 1 |
| 2 | 2003 | 37 | |
| 3 | 2001 | 77 | |
| 4 | 2000 | 1 | |
| 5 | 2000 | 264 | |
| 6 | Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat Hit paper breakdown → | 1999 | 705 |
| 7 | 1998 | 29 | |
| 8 | 1998 | 36 | |
| 9 | 1997 | 12 | |
| 10 | 1997 | 1 | |
| 11 | 1996 | 12 | |
| 12 | 1995 | 63 | |
| 13 | 1994 | 17 | |
| 14 | Relationships between the amount of weight loss and post-heparin lipoprotein lipase activity in patients with type II diabetes. | 1991 | 3 |
| 15 | 1989 | 16 | |
| 16 | 1989 | 8 | |
| 17 | 1983 | 19 | |
| 18 | 1983 | 5 | |
| 19 | 1975 | 9 | |
| 20 | 1965 | 1 |
About Charles Lucas
Charles Lucas is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Pharmacology, Physiology and Pharmacy, having authored 58 papers that have together received 2.9k indexed citations. Recurring topics across this work include Pharmacology and Obesity Treatment (10 papers), Blood Pressure and Hypertension Studies (9 papers), Hormonal Regulation and Hypertension (9 papers), Diabetes Management and Research (6 papers), Diet and metabolism studies (6 papers), Renin-Angiotensin System Studies (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Cardiovascular Function and Risk Factors (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.4k citations), Pharmacology (1.3k citations), Physiology (890 citations), Pharmacy (160 citations) and Endocrine and Autonomic Systems (154 citations). Charles Lucas has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Jonathan Hauptman, Steven B. Heymsfield, Jain Chung, Linda L. Darga, Douglas C. Heimburger, Mario DiGirolamo, Michael Davidson, John P. Foreyt, Charles H. Halsted and David C. Robbins. Their work appears in journals such as The American Journal of Cardiology, Metabolism, The Journal of Clinical Endocrinology & Metabolism, The American Journal of Medicine and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.